Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
10 06 2020
Historique:
received: 04 05 2020
revised: 02 06 2020
accepted: 08 06 2020
entrez: 14 6 2020
pubmed: 14 6 2020
medline: 19 3 2021
Statut: epublish

Résumé

As macrophages exhibit a huge functional plasticity under homeostasis and pathological conditions, they have become a therapeutic target for chronic inflammatory diseases. Hence, the identification of macrophage subset-specific markers is a requisite for the development of macrophage-directed therapeutic interventions. In this regard, the macrophage-specific Folate Receptor β (FRβ, encoded by the

Identifiants

pubmed: 32532019
pii: cells9061445
doi: 10.3390/cells9061445
pmc: PMC7349916
pii:
doi:

Substances chimiques

FOLR2 protein, human 0
Folate Receptor 2 0
Proto-Oncogene Proteins 0
Trans-Activators 0
proto-oncogene protein Spi-1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Invest. 2007 Sep;117(9):2517-25
pubmed: 17786242
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Leukemia. 2016 Jun;30(6):1355-64
pubmed: 26898190
J Immunol. 2018 Jul 15;201(2):635-651
pubmed: 29907708
Nat Rev Rheumatol. 2016 Aug;12(8):472-85
pubmed: 27383913
J Steroid Biochem Mol Biol. 2018 Mar;177:46-52
pubmed: 28870774
J Pharmacol Exp Ther. 2007 May;321(2):462-8
pubmed: 17289839
Sci Rep. 2020 Jan 23;10(1):1047
pubmed: 31974480
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Cell. 2018 Sep 6;174(6):1522-1536.e22
pubmed: 30146161
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
J Immunol. 2016 Sep 15;197(6):2229-38
pubmed: 27534550
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Front Microbiol. 2019 Oct 09;10:2305
pubmed: 31649646
Nat Commun. 2016 May 10;7:11479
pubmed: 27161491
Cell Immunol. 2018 Aug;330:5-15
pubmed: 29475558
Nucleic Acids Res. 2019 Jul 2;47(W1):W158-W165
pubmed: 31165883
J Leukoc Biol. 2009 Aug;86(2):411-21
pubmed: 19406830
Cancer Immunol Immunother. 2009 Oct;58(10):1577-86
pubmed: 19238383
Med Electron Microsc. 2004 Mar;37(1):16-28
pubmed: 15057601
J Exp Med. 2017 Aug 7;214(8):2387-2404
pubmed: 28694385
Nat Immunol. 2005 Jun;6(6):565-70
pubmed: 15895089
Gynecol Oncol. 2008 Mar;108(3):619-26
pubmed: 18222534
Nat Rev Cancer. 2003 Feb;3(2):89-101
pubmed: 12563308
J Immunol. 2016 Feb 1;196(3):1327-37
pubmed: 26729812
Mol Cell Biol. 1994 Jan;14(1):373-81
pubmed: 8264604
Br J Rheumatol. 1997 Sep;36(9):935-40
pubmed: 9376987
J Immunol. 2007 Apr 15;178(8):5245-52
pubmed: 17404308
Arthritis Rheum. 2005 Sep;52(9):2666-75
pubmed: 16142741
Sci Rep. 2017 Aug 8;7(1):7591
pubmed: 28790455
Drug Deliv Transl Res. 2019 Feb;9(1):366-378
pubmed: 30280318
Cancer. 1994 May 1;73(9):2432-43
pubmed: 7513252
Cell Tissue Res. 2008 May;332(2):245-56
pubmed: 18335245
Nat Rev Cancer. 2008 Sep;8(9):683-93
pubmed: 19143053
Immunity. 2017 Aug 15;47(2):235-250.e4
pubmed: 28813657
Cell Res. 2016 Feb;26(2):151-70
pubmed: 26729620
J Immunol. 2017 Mar 1;198(5):2070-2081
pubmed: 28093525
Arthritis Res Ther. 2019 Jun 7;21(1):143
pubmed: 31174578
Science. 1994 Jun 24;264(5167):1948-51
pubmed: 7516582
Cytokine Growth Factor Rev. 2019 Aug;48:24-31
pubmed: 31296363
Circ Res. 2016 Sep 16;119(7):853-64
pubmed: 27444755
Dev Cell. 2002 Apr;2(4):411-23
pubmed: 11970892
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16029-34
pubmed: 25349429
Arthritis Rheum. 1999 Aug;42(8):1609-16
pubmed: 10446858
Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G22-G31
pubmed: 29025731
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5
pubmed: 15070757
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4661-E4669
pubmed: 29712858
Nat Immunol. 2008 Apr;9(4):378-87
pubmed: 18345002
J Clin Invest. 2020 Apr 1;130(4):2081-2096
pubmed: 31945018
Nature. 2014 Apr 24;508(7497):483-7
pubmed: 24739963
Blood. 1998 May 15;91(10):3702-10
pubmed: 9573007
Blood. 2011 May 12;117(19):5092-101
pubmed: 21389328
J Cell Biochem. 2007 Aug 15;101(6):1456-74
pubmed: 17340619
Oncotarget. 2016 Apr 5;7(14):17442-54
pubmed: 26943581
Lancet Oncol. 2015 Aug;16(8):949-56
pubmed: 26179200
J Pathol. 2015 Feb;235(3):515-26
pubmed: 25319955
Nutr Rev. 2004 Jun;62(6 Pt 2):S3-12; discussion S13
pubmed: 15298442
J Biol Chem. 1994 Feb 18;269(7):4725-35
pubmed: 8106441
J Clin Invest. 2015 Apr;125(4):1579-90
pubmed: 25798621
Adv Drug Deliv Rev. 2004 Apr 29;56(8):1067-84
pubmed: 15094207
Blood. 2003 Jun 1;101(11):4551-60
pubmed: 12543860
J Biol Chem. 2005 Sep 30;280(39):33123-31
pubmed: 16051608
Nucleic Acids Res. 2019 Jan 8;47(D1):D729-D735
pubmed: 30462313
J Leukoc Biol. 2016 Sep;100(3):481-9
pubmed: 27354413
J Immunol. 2014 Oct 15;193(8):4245-53
pubmed: 25225663
Cancer. 1999 Jan 15;85(2):348-57
pubmed: 10023702
Immunol Rev. 2000 Apr;174:35-46
pubmed: 10807505
Cell. 2019 Jul 25;178(3):714-730.e22
pubmed: 31348891
Cancer Res. 2009 Dec 15;69(24):9395-403
pubmed: 19951991
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Curr Opin Pharmacol. 2016 Feb;26:10-5
pubmed: 26426255
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Genome Biol. 2016 Aug 22;17(1):174
pubmed: 27549193
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
J Leukoc Biol. 2015 Oct;98(4):453-66
pubmed: 25877931
Sci Rep. 2018 Sep 17;8(1):13948
pubmed: 30224726
Hepatology. 2011 Jan;53(1):306-16
pubmed: 21140375
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Nat Rev Immunol. 2008 Jul;8(7):533-44
pubmed: 18551128
Sci Transl Med. 2018 Apr 11;10(436):
pubmed: 29643229
EMBO J. 2001 Apr 2;20(7):1583-92
pubmed: 11285223
Biochemistry. 1989 Oct 3;28(20):8249-54
pubmed: 2605182
J Immunol. 2013 Mar 1;190(5):2301-10
pubmed: 23355731
Cancer Res. 2016 Jan 1;76(1):35-42
pubmed: 26573801
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
J Immunol. 2012 Jun 1;188(11):5752-65
pubmed: 22547697
Crit Rev Food Sci Nutr. 2020;60(2):244-256
pubmed: 30501511
Int J Cancer. 1996 Jan 3;65(1):112-9
pubmed: 8543387
Blood. 2009 Jan 8;113(2):438-46
pubmed: 18952896
Ann Surg Oncol. 2012 Jul;19(7):2264-71
pubmed: 22350599
Cell. 2011 Nov 11;147(4):868-80
pubmed: 22078883
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925

Auteurs

Rafael Samaniego (R)

Unidad de Microscopia Confocal, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Ángeles Domínguez-Soto (Á)

Centro de Investigaciones Biológicas, CSIC, 28007 Madrid, Spain.

Manohar Ratnam (M)

Barbara Ann Karmanos Cancer Institute and Department of Oncology, Wayne State University, Detroit, MI 48202, USA.

Takami Matsuyama (T)

Department of Immunology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.

Paloma Sánchez-Mateos (P)

Laboratorio de Inmuno-Oncología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Ángel L Corbí (ÁL)

Centro de Investigaciones Biológicas, CSIC, 28007 Madrid, Spain.

Amaya Puig-Kröger (A)

Unidad de InmunoMetabolismo e Inflamación, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH